Th1Th17<sub>CM</sub> Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment.

Mediators Inflamm · 2019 · PMC6617925 · PMID 31346315

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although our results showed a trend of higher percentages of Th1Th17 CM lymphocytes at baseline in DMF patients who develop at least one relapse during the first 12 months of follow-up, our study presents an important limitation in the number of DMF patients who had relapses.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.